Trial Profile
Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis: A Prospective Non-randomized Controlled Trial
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2024
Price :
$35
*
At a glance
- Drugs Terlipressin (Primary)
- Indications Gastric haemorrhage; Haemorrhage; Oesophageal varices
- Focus Therapeutic Use
- 22 Feb 2024 Planned End Date changed from 1 Dec 2024 to 1 Dec 2025.
- 22 Feb 2024 Planned primary completion date changed from 1 Dec 2024 to 1 Dec 2025.
- 22 Feb 2024 Planned initiation date changed from 1 Oct 2023 to 1 Jul 2024.